United States - English - NLM (National Library of Medicine)

honeywell safety products usa, inc - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - first aid antiseptic external analgesic - prevent skin infection - for temporary relief of pain associated with minor burns first aid antiseptic - first aid to help prevent infection in minor cuts, scrapes, and burns eyewash - for flushing the eye to remove loose foreign material, air pollutants or chlorinated water first aid antibiotic first aid antibiotic first aid antibiotic first aid to help prevent infection in - minor cuts - scrapes - burns pain reliever/fever reducer temporarily reduces fever and relieves minor aches and pains associated with: - a cold - headache - toothache - muscular aches - backache - minor pain of arthritis - premenstrual and menstrual periods

United States - English - NLM (National Library of Medicine)

honeywell safety products usa, inc - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - first aid antiseptic external analgesic - prevent skin infection - for temporary relief of pain associated with minor burns first aid antiseptic - first aid to help prevent infection in minor cuts, scrapes, and burns respiratory stimulant - to prevent or treat fainting eyewash - for flushing the eye to remove loose foreign material, air pollutants or chlorinated water first aid antiseptic - first aid to help prevent the risk of infection in minor cuts, scrapes, and burns

United States - English - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3)] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4)]. avelox is indicated in adult patients for the treatment of complicated skin and skin

United States - English - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide 0.5 mg in 1 g - desonate® is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. patients should be instructed to use desonate for the minimum amount of time as necessary to achieve the desired results because of the potential for desonate to suppress the hypothalamic-pituitary-adrenal (hpa) axis [see warnings and precautions (5.1)] . treatment should not exceed 4 consecutive weeks [see dosage and administration (2)]. desonate is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. there are no adequate and well-controlled studies in pregnant women. therefore, desonate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. no r

United States - English - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - azelaic acid (unii: f2vw3d43yt) (azelaic acid - unii:f2vw3d43yt) - azelaic acid .15 g in 1 g - finacea(azelaic acid) foam, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. none. there are no adequate and well-controlled studies in pregnant women. therefore, finacea foam should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. dermal embryofetal developmental toxicology studies have not been performed with azelaic acid, 15% foam. oral embryofetal developmental studies were conducted with azelaic acid in rats, rabbits, and cynomolgus monkeys. azelaic acid was administered during the period of organogenesis in all three animal species. embryotoxicity was observed in rats, rabbits, and monkeys at oral doses of azelaic acid that generated some maternal toxicity. embryotoxicity was observed in rats given 2500 mg/kg/day [162 times the maximum recommended human dose (mrhd) based on body surface area (bsa)], rabbits given 150 or 500 mg/kg/day (19 or 65 times the mrhd based on bsa) and cynomolgus monkeys g

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - baptisia tinctoria 3x gelsemium sempervirens 3x ignatia amara 6x phosphorus 6x pasteurellose 12x tularemia 12x - for the temporary relief of occasional headache, minor muscle or joint pain, fatigue, or skin irritations.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

winco foods, llc - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - uses temporarily relieves itching associated with minor skin irritations, inflammation, and rashes due to: - eczema - psoriasis - jewelry - insect bites - soaps - cosmetics - detergents - seborrheic dermatitis - poison ivy, oak, sumac temporarily relieves external anal and genital itching other uses of this product should only be under the advice and supervision of a doctor do not use - in the genital area if you have a vaginal discharge. consult a doctor. - for the treatment of diaper rash. consult a doctor. - more than directed unless directed by a doctor stop use and ask a doctor if - condition worsens, symptoms persist for more than 7 days or clear up and occur again within a few days, and do not begin use of any other hydrocortisone product unless you have asked a doctor - rectal bleeding occurs directions for itching of skin irritation, inflammation, and rashes: - adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily - children under 2 years of age: ask a

United States - English - NLM (National Library of Medicine)

contract pharmacy services-pa - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) -

United States - English - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - azelaic acid (unii: f2vw3d43yt) (azelaic acid - unii:f2vw3d43yt) - azelaic acid 0.15 g in 1 g - finacea® (azelaic acid) gel, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated. none. there are no adequate and well-controlled studies in pregnant women. therefore, finacea gel should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. dermal embryofetal developmental toxicology studies have not been performed with azelaic acid, 15% gel. oral embryofetal developmental studies were conducted with azelaic acid in rats, rabbits, and cynomolgus monkeys. azelaic acid was administered during the period of organogenesis in all three animal species. embryotoxicity was observed in rats, rabbits, and monkeys at oral doses of azelaic acid that generated some maternal toxicity. e

United States - English - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - interferon beta-1b (unii: ttd90r31wz) (interferon beta-1b - unii:ttd90r31wz) - interferon beta-1b 0.25 mg in 1 ml - betaseron is indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. betaseron is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta, albumin (human), or any other component of the formulation. although there have been no well-controlled studies in pregnant women, available data, which includes prospective observational studies, have not generally indicated a drug-associated risk of major birth defects with interferon beta-1b during pregnancy. administration of betaseron to monkeys during gestation resulted in increased embryo-fetal death at or above exposures greater than 3 times the human therapeutic dose (see animal data ). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk o